Lee Ainslie Regeneron Pharmaceuticals, Inc. Transaction History

Maverick Capital LTD

  • $4.82 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $1.36 Million - $1.55 Million
1,758 New
1,758 $1.54 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $266,305 - $328,775
-490 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $281,274 - $333,670
490 New
490 $297,000
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $281,240 - $357,492
-588 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $320,313 - $387,027
588 New
588 $329,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email